30/01/2025 -
White Paper on ISO 42001:2023 and AI-Driven Medical Devices
 
17/01/2025 -
White Paper on FDA’s Draft Guidance for AI in Healthcare
 
13/01/2025 -
White Paper on Post-Market Surveillance and Vigilance
 
09/12/2024 -
Aligning ISO 13485 with MDR
 
26/11/2024 -
confinis Academy Launch
 
05/11/2024 -
Regulatory Challenges for AI-Enabled Medical Devices
 
31/10/2024 -
White paper on Artificial Intelligence and Auto-Injectors
 
15/10/2024 -
QMSR and FDA QSR & ISO 13485 Harmonization
 
07/10/2024 -
Regulatory Compliance for AI-Enabled Medical Devices
 
23/09/2024 -
Medical Devices Cybersecurity Checklist
 
06/08/2024 -
Medical Devices Threat Modeling
 
23/07/2024 -
New confinis Cybersecurity Services
 
24/05/2024 -
(EU) 2023/607, 26th May 2024 deadline approaching
 
23/05/2024 -
The Future of Health Grant welcomes confinis as a new Program Partner
 
01/05/2024 -
Transitioning to the Medical Device Regulation (MDR) 2017/745
 
11/04/2024 -
Deadline for transitioning to the Medical Device Regulation
 
13/03/2024 -
A Step Forward in Medical Device Manufacturing: the New QMSR Aligned with ISO 13485:2016
 
08/03/2024 -
The EU Artificial Intelligence Act and Medical Device Regulation with Andrea Biasiucci
 
21/02/2024 -
Leveraging Real-World Evidence: Insights and Guidance for Medical Device Manufacturers
 
07/09/2023 -
confinis ag appoints Dario Motti as lead of new Digital Health Competence Cluster
 
03/07/2023 -
Change in Management Structure with Appointment of New CEO at confinis ag
 
02/12/2022 -
The Medical Device Regulation and the medical care for children and rare diseases
 
09/11/2022 -
Working at confinis and the IVDR world with Barbara Jeroncic
 
07/07/2022 -
IVD News – IVDR Date of Application, new Guidance Documents
 
15/06/2022 -
confinis and deep tech with Andrea Biasiucci
 
10/06/2022 -
Electromagnetic Compatibility (EMC) of Medical Devices
 
22/02/2022 -
IVD News – Progressive Roll-Out and MDCG 2022-2 on Clinical Evidence
 
20/12/2021 -
UK Responsible Person Services
 
11/10/2021 -
confinis launches new UK Responsible Person service in UK
 
08/10/2021 -
ISO/FDIS 11608 series opened for voting
 
31/08/2021 -
What is an IVD?
 
06/07/2021 -
confinis partners with Irdeto to launch the first cybersecurity assessment tool in the medical devices industry
 
18/06/2021 -
confinis offers Swiss Representative Service
 
26/05/2021 -
Exporting Swiss Medical Devices to the EU
 
24/04/2021 -
Join our Startup Workshop 2021!
 
23/04/2021 -
… and Report your Post-Market Clinical Follow-up Evaluation!
 
10/03/2021 -
How to plan your post-market clinical follow up…
 
18/02/2021 -
How does the notified body assess your clinical evaluation?
 
28/01/2021 -
How to perform a clinical evaluation for Medical Device Software
 
15/01/2021 -
How to ensure sufficient clinical evidence for legacy devices
 
21/12/2020 -
How to claim an equivalence in the clinical evaluation under the MDR
 
10/12/2020 -
Novelties for Clinical Evaluation and Post Market Surveillance within MDR – the Posts Series
 
03/12/2020 -
Bei Medizinprodukten auf die EU warten hilft der Schweiz wenig
 
29/10/2020 -
Clinical and Performance Evaluation – our 5 strengths at your service
 
16/09/2020 -
confinis partners with b-rayZ concerning innovative Artificial Intelligence project
 
02/09/2020 -
Join us at world’s leading AI in medicine summit!
 
14/08/2020 -
Revision der Schweizer Medizinprodukteverordnung mit Folgen
 
13/07/2020 -
Workshop: Software as a Medical Device (SaMD) in Zürich
 
02/06/2020 -
Interpellation Jacqueline de Quattro on medical devices
 
02/06/2020 -
confinis celebrates 15th anniversary
 
13/05/2020 -
Web based tool to analyze effect of significant changes to devices covered by MDD or AIMDD certificates
 
08/05/2020 -
Politics intervene regarding medical devices
 
07/05/2020 -
Development of medical devices to tackle COVID-19 – UPDATE
 
01/05/2020 -
Swiss Medtech Umfrage: Export in die EU mit Drittstaatanforderungen sichern
 
27/04/2020 -
Peter Studer joins confinis as Senior Advisor
 
14/02/2019 -
EU MDR audit requirements and links to MDSAP program
 
27/12/2018 -
From “Essential Requirements” to “General Safety and Performance Requirements” – EU MDR 2017/745
 
20/12/2018 -
Technical Documentation for medical devices under the new European MDR
 
03/12/2018 -
Conformity Assessment Procedures and Premarket Scrutiny under EU MDR
 
12/11/2018 -
Classification of medical devices under the European Medical Device Regulation 2017/745
 
22/10/2018 -
#MDR – Transition periods and definitions
 
22/09/2018 -
Work in progress: MDR implementation – impact on your Quality Management System (ISO 13485:2016)
 
04/09/2018 -
Your insight to: confinis and its partners – work in progress regarding MDR implementation
 
03/09/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 6)
 
03/09/2018 -
From Investigator to Consulting: On the other side of the fence
 
10/07/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 5)
 
29/06/2018 -
WORKSHOP: PMS under the new European MDR
 
26/06/2018 -
“Quick Wins” for your MDR implementation
 
25/06/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 4)
 
19/06/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 3)
 
11/06/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 2)
 
08/06/2018 -
MDR Article 117 – a look into the Crystal Ball (Part 1)
 
03/04/2018 -
confinis opens US office in the Washington DC area
 
06/02/2018 -
MDR Article 117 – are Combination Product Manufacturers prepared?
 
05/01/2018 -
New year, new energy!
 
10/08/2017 -
Beat Steffen to speak at Medtech & Pharma Platform in Basel
 
10/08/2017 -
Upcoming ISO Technical Report regarding Post Market Surveillance
 
15/02/2017 -
Medical Device Regulation (MDR) and In Vitro Diagnostic Device Regulation (IVDR): Impact on Switzerland
 
  • Home
  • About
  • Services
  • People
  • News
  • Contact us

Tag: post-market-surveillance

… and Report your Post-Market Clinical Follow-up Evaluation!

23 Apr
2021

How to plan your post-market clinical follow up…

10 Mar
2021

Novelties for Clinical Evaluation and Post Market Surveillance within MDR – the Posts Series

10 Dec
2020

subscribe now

interested in regulatory affairs, quality management and news about confinis?

confinis ag
regulatory compliance and beyond

  • LinkedIn

confinis (UK) RP Ltd

St John’s Innovation Centre
Cowley Road Cambridge
CB4 0WS United Kingdom

+44 (0) 1223 421 410
ukrp@confinis.com

confinis ag Switzerland

Hauptstrasse, 1 CH—3186
Düdingen

+41 (0) 26 494 84 94
info.ch@confinis.com

confinis USA Inc.

600 Park Offices Drive
Suite 300 , Unit #50
Durham, NC 27709
United States

+1 910 228 9391
info.usa@confinis.com

© 2025 confinis ag. All rights reserved. Disclaimer & Cookie Policy.
Designed by illo and developed by Dueper Studio
  • Home
  • About
  • Services
  • People
  • News
  • Contact us